Table 2.
Seroprevalence of HIV (Human Immunodeficiency Virus), HCV (Hepatitis C Virus), HBV (Hepatitis B Virus) and Syphilis in the period 2012-2017
| Year | Positive samples (seroprevalence) | Screened Samples | |||
|---|---|---|---|---|---|
| HIV | HCV | HBV | Syphilis | ||
| 2012 | 125 (0.24%) | 116 (0.22%) | 621 (1.20%) | 354 (0.69%) | 51,593 |
| 2013 | 101 (0.18%) | 140 (0.26%) | 596 (1.11%) | 368 (0.67%) | 54,510 |
| 2014 | 135 (0.24%) | 125 (0.22%) | 720 (1.13%) | 437 (0.78%) | 56,155 |
| 2015 | 118 (0.21%) | 92 (0.16%) | 652 (1.14%) | 379 (0.66%) | 57,023 |
| 2016 | 136 (0.20%) | 128 (0.19%) | 985 (1.46%) | 498 (0.74%) | 67,294 |
| 2017 | 110 (0.17%) | 129 (0.20%) | 649 (0.98%) | 260 (0.39%) | 65,685 |